0
Cardiothoracic Surgery |

Thymoma and Good Syndrome

Francina Bolanos, MD; Patricio Santillán Doherty, MD; Emmanuel Peña Gomezportugal, MD; Jaime Omar Herrera Caceres, MD; Mariel Morales, MD; Luis Marcelo Argote Greene, MD
Author and Funding Information

Instituto Nacional de la Nutricion y Ciencias Medicas "Salvador Zubira", Mexico Distrito Federal, Mexico


Chest. 2013;144(4_MeetingAbstracts):96A. doi:10.1378/chest.1702491
Text Size: A A A
Published online

Abstract

SESSION TITLE: Surgery Case Report Posters

SESSION TYPE: Affiliate Case Report Poster

PRESENTED ON: Tuesday, October 29, 2013 at 01:30 PM - 02:30 PM

INTRODUCTION: Good syndrome is a rare condition characterized by the presence of a thymoma, hypogammaglobulinemia and cell mediated defects. There is very little information other than case reports and prognostic of the patients as well as optimal treatment remains uncertain. Good’s syndrome is a rare and the second case reported with thymoma.

CASE PRESENTATION: A female patient in the sixth decade. She had no relevant family history. She was a thyroid goiter diagnosed in 2009 without thyroid function alterations. Laboratory results showed (Hb 10.8 gr/dl) and leucopenia (1900 cel/μl) with lymphopenia (1064 cel/μl; CD4+ 38%) and neutropenia (247 cel/μl). Immunoglobulin levels were low (IgG 300 mg/dl, IgM <20 mg/dl, IgA 46 mg/dl). CT was performed to complete the evaluation reporting an anterior mediastinal mass suggestive of a thymoma measuring 5.5 x 3.4.

DISCUSSION: Hypogammaglobulinemia with thymoma was first described by Robert Good in 1954.(1) It is uncommon, occurring in 3-6% of patients. Features include hypogammaglobulinemia, reduced or absent B-cells, and CD 4+ T-cell dysfunction.(1) The etiology is unclear. Management of Good’s syndrome consists of treating underlying thymoma with surgical resection, chemotherapy and/or radiation. It Quantitative abnormalities in T-cells and immunoglobulins are common. This suggests that defective immune control may result in autoimmune cytopenias and abnormal lymphoproliferation. Thymomas are the most common tumor of the anterior mediastinum, with paraneoplastic syndromes that cause significant morbidity due to immune dysfunction. Good’s syndrome is well-described but uncommmon. Comprehensive testing of immune function is recommended at the time of diagnosis with thymoma.

CONCLUSIONS: This patient was successfully treated by thymectomy which resolved the primary syndrome, diarrhea. Prognostic of patients with Good syndrome remains uncertain. Particularly with patients treated by thymetomy there is no consensus respecting follow-up and long type prognosis. Good syndrome patients should be followed and outcomes reported. Management of Good’s syndrome consists of treating underlying thymoma with surgical resection, chemotherapy and/or radiation.

Reference #1: Kelleher, P; Misbah, SA. What is Good’s Syndrome? Immunological abnormalities in patients with thymoma. Journal of Clinical Pathology 2003; 56: 12-16.

Reference #2: Kondo K, Yoshizawa K, Tsuyuguchi M, Kimura S, et al. WHO Histologic Classification is a Prognostic Indicator in Thymoma.Ann Thorac Surg 2004; 77: 1183-8

Reference #3: Kim D, Yang W, Choi S, Kim K, Chung K. Prognostic and clinical relevance of the World Health Organization Schema for the classification of thymic epithelial tumors. A clinicopathologic study of 108 patients and literature review. Chest 2005; 127: 755-61.

DISCLOSURE: The following authors have nothing to disclose: Francina Bolanos, Patricio Santillán Doherty, Emmanuel Peña Gomezportugal, Jaime Omar Herrera Caceres, Mariel Morales, Luis Marcelo Argote Greene

No Product/Research Disclosure Information


Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Topics

thymoma

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
Pure red cell aplasia. Blood 2016;128(21):2504-2509.
Rabbit Oncology: Diseases, Diagnostics, and Therapeutics. Vet Clin North Am Exot Anim Pract 2017;20(1):135-182.
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543